Tag: NantOmics

Filter

Thought Leadership

Product

Community

NantHealth
NantHealth and ImmunityBio Announce RNA Profiling For Clinical Decision Support Publication In Nature’s Scientific Reports
Study demonstrates the viability and value of RNA sequencing from formalin fixed samples in gaining a deeper understanding of patient...
NantHealth
NantHealth
BioWorld: Other news to note for Oct. 13, 2020
Nanthealth Inc., Nantomics LLC and Immunitybio Inc., all of Culver City, Calif., developed image-based risk models for tumors using images from 82 pancreatic...
NantHealth
NantHealth
Combination of Deep-Learning Models Provides Significant Risk-Assessment of Survival in Pancreatic Cancer Patients, Holding Promise as a Prognostic Technology
NantHealth, ImmunityBio and NantOmics Presented Results at the 2020 AACR Virtual Special Conference: Pancreatic Cancer Culver City, CA – October...
NantHealth
NantHealth
NantOmics and NantHealth Announce Results of Proprietary Machine Vision AI Software Study Demonstrating the Ability to Identify Aggressive Subtypes of...
Study Published In Breast Cancer Research Shows How Deep-Learning Of Over 650 Breast Cancer Digital Pathology Images And Omics Data...
NantHealth
NantHealth
NantHealth and NantOmics Announce GPS Cancer® Platform May Improve Clinical Trial Design of Combination Strategies by Identifying Previously Unrecognized Cancer...
Findings Presented at the ASCO-SITC 2020 Clinical Immuno-Oncology Symposium Orlando, FL and Culver City, CA – February 19, 2020 –...
NantHealth
NantHealth
NantHealth and NantOmics Reveal a Novel AI Based Machine-Learning Digital Pathology Software for Lung Cancer by Identifying Tumor Infiltrating Killer...
Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers Burlingame, CA...
NantHealth

NantHealth